These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25036181)

  • 1. A meta-analysis of mortality in end-stage renal disease patients receiving implantable cardioverter defibrillators (ICDs).
    Chen TH; Wo HT; Chang PC; Wang CC; Wen MS; Chou CC
    PLoS One; 2014; 9(7):e99418. PubMed ID: 25036181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary prevention implantable cardioverter defibrillators in end-stage kidney disease patients on dialysis: a matched cohort study.
    Pun PH; Hellkamp AS; Sanders GD; Middleton JP; Hammill SC; Al-Khalidi HR; Curtis LH; Fonarow GC; Al-Khatib SM
    Nephrol Dial Transplant; 2015 May; 30(5):829-35. PubMed ID: 25404241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of ICDs and CRTs in patients with chronic kidney disease: a meta-analysis of 21,000 patients.
    Shurrab M; Ko DT; Zayed Y; Navaneethan SD; Yadak N; Yaseen A; Kaoutskaia A; Qamhia W; Hamdan Z; Haj-Yahia S; Lee DS; Newman D; Healey JS; Harvey P; Crystal E
    J Interv Card Electrophysiol; 2018 Oct; 53(1):123-129. PubMed ID: 30058056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation.
    Colquitt JL; Mendes D; Clegg AJ; Harris P; Cooper K; Picot J; Bryant J
    Health Technol Assess; 2014 Aug; 18(56):1-560. PubMed ID: 25169727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable Cardioverter Defibrillators for Primary Prevention of Mortality in Patients With Nonischemic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials.
    Stavrakis S; Asad Z; Reynolds D
    J Cardiovasc Electrophysiol; 2017 Jun; 28(6):659-665. PubMed ID: 28316104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic Use of Implantable Cardioverter-Defibrillators in the Prevention of Sudden Cardiac Death in Dialysis Patients.
    Jukema JW; Timal RJ; Rotmans JI; Hensen LCR; Buiten MS; de Bie MK; Putter H; Zwinderman AH; van Erven L; Krol-van Straaten MJ; Hommes N; Gabreëls B; van Dorp W; van Dam B; Herzog CA; Schalij MJ; Rabelink TJ;
    Circulation; 2019 Jun; 139(23):2628-2638. PubMed ID: 30882234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implantable cardiac defibrillators for people with non-ischaemic cardiomyopathy.
    El Moheb M; Nicolas J; Khamis AM; Iskandarani G; Akl EA; Refaat M
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012738. PubMed ID: 30537022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival of patients receiving a primary prevention implantable cardioverter-defibrillator in clinical practice vs clinical trials.
    Al-Khatib SM; Hellkamp A; Bardy GH; Hammill S; Hall WJ; Mark DB; Anstrom KJ; Curtis J; Al-Khalidi H; Curtis LH; Heidenreich P; Peterson ED; Sanders G; Clapp-Channing N; Lee KL; Moss AJ
    JAMA; 2013 Jan; 309(1):55-62. PubMed ID: 23280225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of cardiac resynchronization therapy combined with implantable cardioverter defibrillator for heart failure: a meta-analysis of 5674 patients.
    Chen S; Ling Z; Kiuchi MG; Yin Y; Krucoff MW
    Europace; 2013 Jul; 15(7):992-1001. PubMed ID: 23419662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF.
    Wilcox JE; Fonarow GC; Zhang Y; Albert NM; Curtis AB; Gheorghiade M; Heywood JT; Mehra MR; O'Connor CM; Reynolds D; Walsh MN; Yancy CW
    Circ Heart Fail; 2014 Jan; 7(1):146-53. PubMed ID: 24178311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescription of Guideline-Recommended Implantable Cardioverter Defibrillator and Cardiac Resynchronization Therapy Among Patients Hospitalized With Heart Failure and Varying Degrees of Renal Function.
    Pun PH; Sheng S; Sanders G; DeVore AD; Friedman D; Fonarow GC; Heidenreich PA; Yancy CW; Hernandez AF; Al-Khatib SM
    Am J Cardiol; 2017 Mar; 119(6):886-892. PubMed ID: 28160975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal dialysis as a risk factor for appropriate therapies and mortality in implantable cardioverter-defibrillator recipients.
    Robin J; Weinberg K; Tiongson J; Carnethon M; Reddy M; Ciaccio C; Quadrini M; Hsu J; Fan J; Choi P; Kadish A; Goldberger J; Passman R
    Heart Rhythm; 2006 Oct; 3(10):1196-201. PubMed ID: 17018351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do implantable cardioverter defibrillators improve survival in patients with chronic kidney disease at high risk of sudden cardiac death? A meta-analysis of observational studies.
    Makki N; Swaminathan PD; Hanmer J; Olshansky B
    Europace; 2014 Jan; 16(1):55-62. PubMed ID: 24058182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procedural outcomes and long-term survival following trans-venous defibrillator lead extraction in patients with end-stage renal disease.
    Shah AD; Peddareddy LP; Addish MA; Kelly K; Patel AU; Casey M; Goyal A; Leon AR; El-Chami MF; Merchant FM
    Europace; 2017 Dec; 19(12):1994-2000. PubMed ID: 28065887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between CRT(D)/ICD and renal insufficiency: A systematic review and meta-analysis.
    Liu Y; Sun JY; Zhu YS; Li ZM; Li KL; Wang RX
    Semin Dial; 2021 Jan; 34(1):17-30. PubMed ID: 33296540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real world effectiveness of primary implantable cardioverter defibrillators implanted during hospital admissions for exacerbation of heart failure or other acute co-morbidities: cohort study of older patients with heart failure.
    Chen CY; Stevenson LW; Stewart GC; Bhatt DL; Desai M; Seeger JD; Williams L; Jalbert JJ; Setoguchi S
    BMJ; 2015 Jul; 351():h3529. PubMed ID: 26174233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable cardioverter-defibrillators and survival in advanced heart failure patients with continuous-flow left ventricular assist devices: a systematic review and meta-analysis.
    Elkaryoni A; Badarin FA; Khan MS; Ellakany K; Potturi N; Poonia J; Kennedy KF; Magalski A; Sperry BW; Wimmer AP
    Europace; 2019 Sep; 21(9):1353-1359. PubMed ID: 31086951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantable cardioverter-defibrillator use in elderly patients receiving cardiac resynchronization: A meta-analysis.
    AlTurki A; Proietti R; Alturki H; Essebag V; Huynh T
    Hellenic J Cardiol; 2019; 60(5):276-281. PubMed ID: 29292244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality reduction of cardiac resynchronization and implantable cardioverter-defibrillator therapy in heart failure: an updated meta-analysis. Does recent evidence change the standard of care?
    Bertoldi EG; Polanczyk CA; Cunha V; Ziegelmann PK; Beck-da-Silva L; Rohde LE
    J Card Fail; 2011 Oct; 17(10):860-6. PubMed ID: 21962425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
    Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.